Journal of Cardiovascular Disease Research
A Study of Plasma Myeloperoxidase Levels in Chronic Heart Failure: Prognostic Significance and Echocardiographic Factors
Dr Saurabh Jain , Dr Shrey Chetankumar Mehta , Dr Himaja Reddy Garlapati , Dr Karmarajsinh Dilipsinh Vaghela
JCDR. 2023: 2147-2159
Abstract
Background: An important biomarker for chronic heart failure is raised plasma myeloperoxidase (MPO) concentrations, which indicate increased oxidative stress and leukocyte activation. When managing this intricate cardiovascular condition, monitoring MPO levels provides information for prognosis and customized therapies.
» PDF